James S Starman
- Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective reviewJames S Starman
Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, North Carolina 28203, USA
J Trauma Acute Care Surg 72:676-81. 2012..This retrospective study was performed to assess radiographic outcomes of off-label uses of BMP-2 for acute fractures and nonunions at our institution...
- Proximal tibial metaphyseal fractures with severe soft tissue injury: clinical and functional results at 2 yearsJames S Starman
Department of Orthopaedic Surgery, Carolinas Medical Center, 1616 Scott Avenue, Charlotte, NC, 28203, USA
Clin Orthop Relat Res 468:1669-75. 2010..Controversy exists regarding management of proximal tibial metaphyseal fractures with severe soft tissue injury. It is unclear whether limb salvage or early amputation results in the best functional and clinical outcomes...
- Genomewide molecular and biologic characterization of biomembrane formation adjacent to a methacrylate spacer in the rat femoral segmental defect modelHelen E Gruber
Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC Health Research Group, Rockbridge Baths, VA
J Orthop Trauma 27:290-7. 2013..The objective of this research was to assess the biomembrane formed in a novel rodent femoral segmental defect model at 4, 8, and 16 weeks with histologic and molecular studies...
- Utilization of the AO LockingRatNail in a novel rat femur critical defect modelHarvey E Montijo
Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, NC 28232, USA
J Invest Surg 25:381-6. 2012..This model is needed for future studies where materials in the critical defect could be modified with agents to fight infection (antibiotics) or promote osteogenesis...